Our news
Key figures
Over 20.000
employees
Close to 130
countries in which the Group’s medicines are distributed
Close to 20%
of revenue from brand-name medicines invested in R&D each year
€ 6.9 billion
euros in revenue in 2024/2025
3 therapeutic areas
Oncology, neurology, cardiometabolism & venous diseases
What moves us
Because passing on to future generations a world that can ensure access to quality healthcare for all is our vision for the future, at Servier, around the world, we are ready to meet the healthcare challenges of tomorrow, for and with patients.
Discover our corporate video